| Product Code: ETC13369753 | Publication Date: Apr 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 150 | No. of Figures: 55 | No. of Tables: 32 |
Africa Vaccine Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Africa Vaccine Market Overview |
3.1 Africa Regional Macro Economic Indicators |
3.2 Africa Vaccine Market Revenues & Volume, 2021 & 2031F |
3.3 Africa Vaccine Market - Industry Life Cycle |
3.4 Africa Vaccine Market - Porter's Five Forces |
3.5 Africa Vaccine Market Revenues & Volume Share, By Countries, 2021 & 2031F |
3.6 Africa Vaccine Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.7 Africa Vaccine Market Revenues & Volume Share, By Disease Indication, 2021 & 2031F |
3.8 Africa Vaccine Market Revenues & Volume Share, By Age Group, 2021 & 2031F |
3.9 Africa Vaccine Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.10 Africa Vaccine Market Revenues & Volume Share, By Technology, 2021 & 2031F |
4 Africa Vaccine Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Africa Vaccine Market Trends |
6 Africa Vaccine Market, 2021 - 2031 |
6.1 Africa Vaccine Market, Revenues & Volume, By Type, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 Africa Vaccine Market, Revenues & Volume, By Preventive Vaccines, 2021 - 2031 |
6.1.3 Africa Vaccine Market, Revenues & Volume, By Therapeutic Vaccines, 2021 - 2031 |
6.1.4 Africa Vaccine Market, Revenues & Volume, By DNA Vaccines, 2021 - 2031 |
6.2 Africa Vaccine Market, Revenues & Volume, By Disease Indication, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 Africa Vaccine Market, Revenues & Volume, By Influenza, 2021 - 2031 |
6.2.3 Africa Vaccine Market, Revenues & Volume, By COVID19, 2021 - 2031 |
6.2.4 Africa Vaccine Market, Revenues & Volume, By Hepatitis B, 2021 - 2031 |
6.3 Africa Vaccine Market, Revenues & Volume, By Age Group, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 Africa Vaccine Market, Revenues & Volume, By Pediatrics, 2021 - 2031 |
6.3.3 Africa Vaccine Market, Revenues & Volume, By Adults, 2021 - 2031 |
6.3.4 Africa Vaccine Market, Revenues & Volume, By Geriatrics, 2021 - 2031 |
6.4 Africa Vaccine Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
6.4.1 Overview & Analysis |
6.4.2 Africa Vaccine Market, Revenues & Volume, By Intramuscular, 2021 - 2031 |
6.4.3 Africa Vaccine Market, Revenues & Volume, By Subcutaneous, 2021 - 2031 |
6.4.4 Africa Vaccine Market, Revenues & Volume, By Oral, 2020 - 2028 |
6.5 Africa Vaccine Market, Revenues & Volume, By Technology, 2020 - 2028 |
6.5.1 Overview & Analysis |
6.5.2 Africa Vaccine Market, Revenues & Volume, By mRNAbased, 2020 - 2028 |
6.5.3 Africa Vaccine Market, Revenues & Volume, By Viral Vector, 2020 - 2028 |
6.5.4 Africa Vaccine Market, Revenues & Volume, By Protein Subunit, 2020 - 2028 |
7 Africa Vaccine Market, By Countries, 2021 - 2031 |
7.1 Overview & Analysis |
7.2 Africa Vaccine Market, Revenues & Volume, By Type, 2021 - 2031 |
7.2.1 South Africa Vaccine Market, Revenues & Volume, By Type, 2021 - 2031 |
7.2.2 Egypt Vaccine Market, Revenues & Volume, By Type, 2021 - 2031 |
7.2.3 Nigeria Vaccine Market, Revenues & Volume, By Type, 2021 - 2031 |
7.2.4 Rest of Africa Vaccine Market, Revenues & Volume, By Type, 2021 - 2031 |
7.3 Africa Vaccine Market Revenues & Volume Share, By Disease Indication, 2021 & 2031F |
7.3.1 South Africa Vaccine Market, Revenues & Volume, By Disease Indication, 2021 - 2031 |
7.3.2 Egypt Vaccine Market, Revenues & Volume, By Disease Indication, 2021 - 2031 |
7.3.3 Nigeria Vaccine Market, Revenues & Volume, By Disease Indication, 2021 - 2031 |
7.3.4 Rest of Africa Vaccine Market, Revenues & Volume, By Disease Indication, 2021 - 2031 |
7.4 Africa Vaccine Market, Revenues & Volume, By Age Group, 2021 - 2031 |
7.4.1 South Africa Vaccine Market, Revenues & Volume, By Age Group, 2021 - 2031 |
7.4.2 Egypt Vaccine Market, Revenues & Volume, By Age Group, 2021 - 2031 |
7.4.3 Nigeria Vaccine Market, Revenues & Volume, By Age Group, 2021 - 2031 |
7.4.4 Rest of Africa Vaccine Market, Revenues & Volume, By Age Group, 2021 - 2031 |
7.5 Africa Vaccine Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
7.5.1 South Africa Vaccine Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
7.5.2 Egypt Vaccine Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
7.5.3 Nigeria Vaccine Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
7.5.4 Rest of Africa Vaccine Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
7.6 Africa Vaccine Market, Revenues & Volume, By Technology, 2021 - 2031 |
7.6.1 South Africa Vaccine Market, Revenues & Volume, By Technology, 2021 - 2031 |
7.6.2 Egypt Vaccine Market, Revenues & Volume, By Technology, 2021 - 2031 |
7.6.3 Nigeria Vaccine Market, Revenues & Volume, By Technology, 2021 - 2031 |
7.6.4 Rest of Africa Vaccine Market, Revenues & Volume, By Technology, 2021 - 2031 |
8 Africa Vaccine Market Key Performance Indicators |
9 Africa Vaccine Market - Export/Import By Countries Assessment |
10 Africa Vaccine Market - Opportunity Assessment |
10.1 Africa Vaccine Market Opportunity Assessment, By Countries, 2021 & 2031F |
10.2 Africa Vaccine Market Opportunity Assessment, By Type, 2021 & 2031F |
10.3 Africa Vaccine Market Opportunity Assessment, By Disease Indication, 2021 & 2031F |
10.4 Africa Vaccine Market Opportunity Assessment, By Age Group, 2021 & 2031F |
10.5 Africa Vaccine Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
10.6 Africa Vaccine Market Opportunity Assessment, By Technology, 2021 & 2031F |
11 Africa Vaccine Market - Competitive Landscape |
11.1 Africa Vaccine Market Revenue Share, By Companies, 2022 |
11.2 Africa Vaccine Market Competitive Benchmarking, By Operating and Technical Parameters |
12 Top 10 Company Profiles |
13 Recommendations |
14 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here